VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,751,864 | +11.3% | 436,709 | +24.5% | 4.23% | +18.6% |
| Q2 2023 | $10,559,997 | +2.1% | 350,714 | +9.7% | 3.57% | +5.2% |
| Q1 2023 | $10,344,020 | +46.9% | 319,753 | +30.2% | 3.39% | +52.5% |
| Q4 2022 | $7,040,432 | +126.2% | 245,654 | +90.4% | 2.22% | +108.5% |
| Q3 2022 | $3,112,000 | +12.5% | 129,026 | +27.7% | 1.07% | +28.4% |
| Q2 2022 | $2,766,000 | +14.7% | 101,009 | +60.6% | 0.83% | +29.5% |
| Q1 2022 | $2,412,000 | +31.8% | 62,903 | +10.1% | 0.64% | +33.0% |
| Q4 2021 | $1,830,000 | +61.2% | 57,145 | +48.4% | 0.48% | +53.5% |
| Q3 2021 | $1,135,000 | +38.9% | 38,513 | +60.2% | 0.31% | +43.4% |
| Q2 2021 | $817,000 | +50.5% | 24,038 | +43.9% | 0.22% | +47.0% |
| Q1 2021 | $543,000 | – | 16,700 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |